To further validate TP73-AS1 as a clinical diagnostic or prognostic biomarker across multiple cancers, we first evaluated differences in TP73-AS1 expression between normal and tumor samples using unpaired Wilcoxon rank-sum and signed-rank tests. The gene discussed is TP73; the disease is neoplasm.